Mechanistically, miR-218-5p inhibited microglia IFN-I responses and inflammation by targeting Ddx41. Hence, miR-218-5p-Ddx41 is a promising therapeutic target for PD. The gene discussed is DDX41; the disease is Parkinson disease.